Congrats to colleagues, partners & team, with numerous #aao2021 & AUS presentati…
[ad_1]
Congrats to colleagues, partners & team, with numerous #aao2021 & AUS presentations on #suprachoroidal delivery, utilizing the SCS Microinjector. Beyond recently FDA-approved #Xipere, 4 clinical trials are now assessing 3 suprachoroidal therapies.
#eye #retina #genetherapy https://t.co/25TR3ccT06
[ad_2]
Source by Thomas Ciulla, MD, MBA